#bcd_aacr
LightNews LightNews
mtmdphd.bsky.social
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm
January 26, 2025 at 12:00 AM
mtmdphd.bsky.social
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm
December 18, 2024 at 1:41 PM
onco404.bsky.social
A recent study highlights bispecific antibodies #BsAbs as a powerful bridging therapy before BCMA CAR-T cell treatment for relapsed/refractory multiple myeloma #RRMM

@theaacr.bsky.social #bcd_aacr

#Onco404 #Cancer #Kanser #MultipleMyeloma #CARTCellTherapy #MedSky #Immunotherapy #Hematology
May 13, 2025 at 4:23 PM
tanyabondar.bsky.social
Now online @BCD_AACR: Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
#MMsm #CARTcell #microbiome #immunotherapy
aacrjournals.org/bloodcancerd...
August 18, 2025 at 12:04 PM
mtmdphd.bsky.social
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
Patients treated recently for a B-lymphoid malignancy are shown to have particularly high risks of severe COVID-19 compared to multiple control cohorts of patients with cancer and COVID-19.
ow.ly
November 18, 2024 at 1:26 AM
mtmdphd.bsky.social
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm
May 19, 2025 at 11:14 PM
mtmdphd.bsky.social
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm
February 14, 2025 at 1:34 PM
mtmdphd.bsky.social
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm
February 3, 2025 at 12:26 AM
quaidmorris.bsky.social
Pairtree is in press @BCD_AACR: https://aacrjournals.org/bloodcancerdiscov/article/doi/10.1158/2643-3230.BCD-21-0092/682021/Reconstructing-complex-cancer-evolutionary

FYI here's our tweetorial from last year: https://x.com/quaidmorris/status/1381891967014027264

Update: the...
quaidmorris.bsky.social Quaid Morris @quaidmorris.bsky.social · Apr 13
I am excited to introduce Pairtree: the first automated method that can reliably reconstruct complex evolutionary histories from bulk cancer DNA sequencing data. 🧵

https://www.biorxiv.org/content/10.1101/2020.11.06.372219v2
November 18, 2024 at 3:08 PM
quaidmorris.bsky.social
Pairtree is in press @BCD_AACR: https://aacrjournals.org/bloodcancerdiscov/article/doi/10.1158/2643-3230.BCD-21-0092/682021/Reconstructing-complex-cancer-evolutionary

FYI here's our tweetorial from last year: https://x.com/quaidmorris/status/1381891967014027264

Update: the...
quaidmorris.bsky.social Quaid Morris @quaidmorris.bsky.social · Apr 13
I am excited to introduce Pairtree: the first automated method that can reliably reconstruct complex evolutionary histories from bulk cancer DNA sequencing data. 🧵

https://www.biorxiv.org/content/10.1101/2020.11.06.372219v2
November 16, 2024 at 1:05 PM